Hostname: page-component-78c5997874-94fs2 Total loading time: 0 Render date: 2024-11-10T06:54:51.120Z Has data issue: false hasContentIssue false

Health first, for all: Envisioning a novel complementary pathway for translational research

Published online by Cambridge University Press:  18 August 2023

Kevin Fiscella*
Affiliation:
Department of Family Medicine, University of Rochester, Rochester, NY, USA
Reza Yousefi Nooraie
Affiliation:
Department of Public Health Sciences, University of Rochester, Rochester, NY, USA
*
Corresponding author: K. Fiscella, MD, MPH; Email: kevin_fiscella@urmc.rochester.edu
Rights & Permissions [Opens in a new window]

Abstract

Type
Perspective
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of The Association for Clinical and Translational Science

Prior to the COVID-19 pandemic, US life expectancy was declining [Reference Woolf1]. Psychological distress has risen over the past decades [Reference Blanchflower and Oswald2]. Among high-income countries, US life expectancy declined the most during the pandemic [Reference Woolf, Masters and Aron3]. Scientific innovation in the USA seems to be slowing [Reference Park, Leahey and Funk4]. The current biomedical translational pathway alone may be insufficient for improving population health and health equity in the USA [Reference Fiscella and Epstein5]. The NIH strategic plan identifies “Health Promotion and Disease Prevention” among its top three research priorities [6]. To address this national crisis, we propose a novel, complementary pathway for translational research: “Health First, for All.”

The Biomedical Research Translational Pathway Benefits and Limits

NIH’s core mission is biomedical research, with more than half of its budget spent on basic biomedical and behavioral research [7]. Biomedical research has yielded groundbreaking successes – mapping the human genome, discovery of the gene-editing tool CRISPR, and novel treatments for viral infections and various cancers.

Yet, there are fundamental limits to the biomedical pathway. First, its basic, disease-based model of health is limited in scope because it ignores the positive aspects of health that are important to people and communities, including agency, resilience, adaptability, and well-being [8]. It misses opportunities for discovering how to optimize all people’s potential for health, particularly by addressing behavioral, environmental, and social determinants of health. Second, it is not optimized for improving health because it begins with the discovery of biomedical mechanisms that may or may not ultimately translate into population health benefits over its 17-year time course. Last, the biomedical pathway often ends with FDA approval, failing to cross “the second valley” of death, that is, adoption of the innovation for the benefit of all people [Reference Wizemann, Nass and Andrada9].

A Health First, for All Pathway for Translational Research

We propose a novel, complementary pathway based on three principles. First, this research pathway should start with the end goal of promoting health for all (rather than basic discovery relevant to diseases) and target health determinants (rather than mechanisms). Second, this pathway should begin with research on optimal strategies for addressing health determinants, particularly human material and psychological needs, that is, autonomy, competence, and relatedness [Reference Ntoumanis, Ng and Prestwich10], that promote well-being and capability for health with an equity lens. This research should be conducted in full partnership with residents of communities, particularly those marginalized, starting with community priorities for health and corresponding determinants, aiming for meaningful and sustainable engagement and co-ownership [Reference Aguilar-Gaxiola, Ahmed and Anise11]. Third, this complementary pathway should be based on long-term partnerships with potential intervention adopters including communities and healthcare based on team science principles [Reference Selker and Wilkins12]. Identifying and addressing behavioral (e.g., physical activity, nutrition, mental health, etc.), environmental, and social determinants of health requires long-term, multisectoral funding, co-led community partnerships, cross-training among partnership members, and the application of equity-sensitized implementation science to communities and healthcare organizations. This requires genuine co-ownership of the process beginning with identifying priorities related to determinants of health and beginning by generating new evidence and adapting current evidence-based interventions to address community-identified priorities. When interventions are lacking, these community–research partnerships can activate “reverse translation” pathways to inform efficacy or even basic studies to develop new interventions [Reference Shakhnovich13]. Conversely, when barriers to translation exist, dissemination and implementation research can address implementation barriers at various levels including health-related policies [Reference Purtle, Peters and Brownson14,Reference Emmons and Chambers15].

Implementing a Health First, for All Research Translational Pathway

Implementation of a second translational pathway that interdigitates with the biomedical pathway is daunting (Fig. 1). To start, a national definition of health is needed beyond the absence of disease that acknowledges the fundamental human aspects of health [Reference Fiscella and Epstein5]. Creating such a definition should involve a participatory process that includes federal departments and agencies working with communities and informed by the National Academies (NASEM) report on achieving whole health [16].

Figure 1. Current translational pathway (upper diagram) and proposed complementary Health First, for All pathway (lower diagram).

A long-term research agenda coupled with appropriate funding is needed for promoting and optimizing health. Establishing this agenda should begin with an NIH strategic plan in conjunction with diverse and marginalized communities. Potentially, the NCATS with additional funding could support this second “Health First, for All” translational pathway. This research agenda is urgently needed to inform the implementation of NASEM’s and VA’s whole health model and related value-based payment models [16,17].

Last, there is a need to cross the “second valley of death” with long-term funding for infrastructure and training required for partnerships between researchers, communities, and healthcare organizations to create a context for generating scientific knowledge on pragmatic strategies to address population health determinants. These co-led research–community–healthcare partnerships will require new models for collaboration and new delivery models for generating new evidence (with emphasis on appropriateness and diversity of perspectives and priorities) and testing strategies for the adoption of evidence-based, culturally adapted interventions [Reference Oliver and Boaz18]. These tripartite partnerships must begin with local health priorities and chosen evidence-based interventions and involve adaptations to local needs, implementation of strategies based on context, adoption of steps to ensure sustainability, methodologically rigorous assessments of health impact and equitable implementation processes. One potential approach to organizing programs across these entities around health determinants is to scale models like the NIH Compass program [19].

Potential Benefits

Our national health is in precipitous decline [Reference Woolf1]. The current biomedical translational research pathway is insufficient to reverse this crisis. We urgently need a second, synergistic rescue pathway. Starting with communities’ desired health outcomes and conducting collaborative research on how to optimize the adoption of current evidence for the benefit of all could shorten the time needed to improve population health. By prioritizing elements of health and health promotion that are most impactful and meaningful to people and their communities, this approach offers the potential for improving health in ways that matter most to people.

Roughly 90% of healthcare spending in the USA goes to people with chronic physical and mental conditions [20]. A “Health First, for All” pathway offers the potential to interrupt this vicious cycle by generating scientific knowledge to guide the optimization of individual and community health and well-being while addressing key determinants that yield inequities in health. Doing so could forestall chronic disease and ultimately slow unstainable growth in healthcare spending. Most importantly, this second translational pathway is critical to reversing our national decline in health and addressing long-standing health equities.

Acknowledgments

The authors would like to thank Joann Leslie for her assistance in preparing this perspective.

Funding statement

KF and RYN were supported by the National Center for Advancing Translational Sciences, National Institutes of Health, Award Number UL1 TR002001. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or NCATS.

Competing interests

The authors have no conflicts of interest to declare.

References

Woolf, SH. Falling behind: the growing gap in life expectancy between the United States and other countries, 1933-2021. Am J Public Health. 2023;0:e1e11.Google Scholar
Blanchflower, DG, Oswald, AJ. Trends in extreme distress in the United States, 1993-2019. Am J Public Health. 2020;110(10):15381544.CrossRefGoogle ScholarPubMed
Woolf, SH, Masters, RK, Aron, LY. Effect of the covid-19 pandemic in 2020 on life expectancy across populations in the USA and other high income countries: simulations of provisional mortality data. Bmj. 2021;373:n1343.CrossRefGoogle ScholarPubMed
Park, M, Leahey, E, Funk, RJ. Papers and patents are becoming less disruptive over time. Nature. 2023;613(7942):138144.CrossRefGoogle ScholarPubMed
Fiscella, K, Epstein, RM. The profound implications of the meaning of health for health care and health equity. Milbank Q. 2023;101(3):0721. doi: 10.1111/1468-0009.12660.Google Scholar
NIH. NIH-Wide Strategic Plan, Fiscal Years 2021-2025. https://www.nih.gov/sites/default/files/about-nih/strategic-plan-fy2021-2025-508.pdf. Published 2021. Accessed, 8/11/2023.Google Scholar
World Health Organization. The 1st International Conference on Health Promotion, Ottawa, 1986. https://www.who.int/teams/health-promotion/enhanced-wellbeing/first-global-conference. Published 1986. Accessed 8/11/2023.Google Scholar
National Academies of Sciences, Engineering, and Medicine. Wizemann, T, Nass, SJ, Andrada, A, et al. eds. The role of NIH in drug development innovation and its impact on patient access: proceedings of a workshop. 2020. Washington (DC): National Academies Press (US); 2019.Google Scholar
Ntoumanis, N, Ng, JY, Prestwich, A, et al. A meta-analysis of self-determination theory-informed intervention studies in the health domain: effects on motivation, health behavior, physical, and psychological health. Health Psychol Rev. 2021;15(2):214244.CrossRefGoogle ScholarPubMed
Aguilar-Gaxiola, S, Ahmed, SM, Anise, A, et al. Assessing meaningful community engagement: a conceptual model to advance health equity through transformed systems for health: organizing committee for assessing meaningful community engagement in health & health care programs & policies, NAM Perspective. Washington, DC: National Academy of Medicine; 2022.Google Scholar
Selker, HP, Wilkins, CH. From community engagement, to community-engaged research, to broadly engaged team science. J Clin Transl Sci. 2017;1(1):56.CrossRefGoogle ScholarPubMed
Shakhnovich, V. It’s time to reverse our thinking: the reverse translation research paradigm. Clin Transl Sci. 2018;11(2):9899.CrossRefGoogle ScholarPubMed
Purtle, J, Peters, R, Brownson, RC. A review of policy dissemination and implementation research funded by the National Institutes of Health, 2007-2014. Implement Sci. 2016;11(1):1.CrossRefGoogle ScholarPubMed
Emmons, KM, Chambers, DA. Policy implementation science - an unexplored strategy to address social determinants of health. Ethn Dis. 2021;31(1):133138.CrossRefGoogle ScholarPubMed
National Academies of Sciences, Engineering, and Medicine. Achieving Whole Health: A New Approach for Veterans and the Nation. Washington, DC: The National Academies Press; 2023. https://doi.org/10.17226/26854. Accessed 8/11/2023.Google Scholar
Ma S, Zhou Q, Agrawal S. Pay For What Matters To Patients: A Whole Health Population-Based Payment Approach. Health Affairs Forefront, July 5, 2023. https://www.healthaffairs.org/content/forefront/pay-matters-patients-whole-health-population-based-payment-approach. Accessed 8/11/2023.Google Scholar
Oliver, K, Boaz, A. Transforming evidence for policy and practice: creating space for new conversations. Palgrave Commun. 2019;5(1):1–0.CrossRefGoogle Scholar
NIH Office of Strategic Coordination - The Common Fund. Community Partnerships to Advance Science for Society (ComPASS). National Institutes of Health. Published 2023. https://commonfund.nih.gov/compass. Accessed 05/10/2023.Google Scholar
Centers for Disease Control and Prevention, Center for Disease Prevention and Health Promotion. Health and Economic Costs of Chronic Diseases. Centers for Disease Control and Disease Prevention. https://www.cdc.gov/chronicdisease/index.htm. Published 2023. Accessed 8/11/2023.Google Scholar
Figure 0

Figure 1. Current translational pathway (upper diagram) and proposed complementary Health First, for All pathway (lower diagram).